Le Lézard
Classified in: Health, Business
Subjects: PDT, JVN, PET

Petsecure-CVMA Partnership Brings the Working Mind to Support Veterinary Teams


WINNIPEG, MB, April 30, 2024 /CNW/ - Petsecure Pet Health Insurance, the flagship brand of a dynamic pet insurance company, is excited to announce its new partnership with the Canadian Veterinary Medical Association (CVMA) to deliver an empowering mental health program to veterinary teams.

The Working Mind training course addresses the inherent workplace stresses experienced by many people in the veterinary profession.

"Veterinary practices employ very resilient folks who move from the joys of fluffy kitten wellness exams in one room to the sorrow of euthanasia of a pet in the next ? and all the emotions and experiences in between. At Petsecure, we believe in solutions that allow veterinary teams to do what they do best ? practice great veterinary medicine. Sponsorship of The Working Mind Program reflects our commitment to our colleagues who are dealing with the highs and lows of caring for animals every day," shares Dr. Colleen Fisher, Petsecure's Veterinary Medical Director and longtime member of the CVMA.

"We are grateful to Petsecure for supporting this important program," says Dr. Trevor Lawson, CVMA President. "It is clear from participant feedback that The Working Mind courses teach healthy coping mechanisms for dealing with stress. This, in turn, cultivates a healthy work culture which positively correlates with high well-being, low burnout, and absence of serious psychological distress in veterinary professionals. It is imperative that we offer this type of support to our hard-working veterinary teams so we can ensure a healthy and safe future for animals, clients, and the public."  

Veterinary managers and employees who have attended the program report improved attitudes toward mental health distress, increased resiliency during difficult times, and an overall increase in mental and emotional wellness.

Petsecure is dedicated to solutions that build mental readiness and improve the practice culture, so veterinary teams can offer the best care for their animal patients and human clients. While new advancements in veterinary care allow for lifesaving treatments, these procedures may not fit the budget of every loving pet owner. Petsecure plans offer customizable premium and benefit options for Canadian dog and cat owners to help cover unexpected veterinary fees.

The Working Mind is more than a mental health program; it is a strategic investment in the passion and expertise of Canadian veterinary professionals as they offer great care to their furry patients.

About the Canadian Veterinary Medical Association

The Canadian Veterinary Medical Association (CVMA) is the national and international voice for Canada's veterinarians, providing leadership and advocacy for veterinary medicine. Visit CanadianVeterinarians.net to learn more.

About Petline Insurance Company   

As the first licensed insurance company in Canada to focus solely on pet insurance, Petline is a leader in the pet insurance market since 1989. Petline Insurance Company operates under the Definity family of companies and has a number of product lines. Their flagship brand is Petsecure pet health insurance, and they launched Peppermint Pet Health Insurance in 2018 as their lower-cost option. Petline also underwrites for OVMA Pet Health Insurance, Pet Insurance for Hudson's Bay customers, Desjardins Pet Insurance Program, The Personal Pet Insurance Program, Toronto Humane Society Pet Health Insurance, and Nova Scotia SPCA Pet Health Insurance. Each brand offers distinct coverage options with unique benefits at varying price points. Petline helps Canadian pets live longer and healthier lives by enabling their owners to provide the best in pet health care.  

SOURCE Petsecure


These press releases may also interest you

at 03:12
GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo Syndrome Type A) treatment, GC1130A....

at 03:05
PathAI, a global leader in AI-powered pathology, today announced a new Early Access Program (EAP) to drive adoption of its AISightTM Image Management System (IMS) in Mainland Europe.1 Earlier in 2023, PathAI announced a similar program for...

at 03:00
Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers, today announces the completion of a $120m Series B financing to fund the development of its...

at 03:00
YGION Biomedical GmbH, a company dedicated to developing individualized neoantigen-based cancer vaccines, today announced the completion of a Series A financing round of ?15 million from an Austrian private trust. The proceeds will be used to further...

at 02:59
Allied Market Research has recently published a report, titled, "Biometric Cards Market Size, Share, Competitive Landscape and Trend Analysis...

at 02:05
Today AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing oncology, biopharmaceuticals and rare disease portfolio, and...



News published on and distributed by: